DUBLIN--(BUSINESS WIRE)--The "Cancer Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.
The report predicts the global cancer drugs market to grow with a CAGR of 7.2% over the forecast period from 2018-2024.
The study on cancer drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.
The report on the cancer drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cancer drugs market over the period of 2016 to 2024.
- Growing Occurrence of Different Types of Cancer
- Increasing Concerns related High Death Rates due to Cancer
- Advancement in Cancer Treatment Technology
- High Cost of Cancer Treatments
- Introduction of Novel Cancer Drugs Products
- Bayer AG
- Eli Lilly and Company
- Novartis AG
- Amgen Inc.
- GlaxoSmithKline PLC
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Merck & Co. Inc.
- Celgene Corporation
- Boehringer Ingelheim International GmbH
Key Topics Covered
2. Executive Summary
3. Global Cancer Drugs Market Overview
4. Cancer Drugs Market Macro Indicator Analysis
5. Global Cancer Drugs Market by Types
6. Global Cancer Drugs Market by Application
7. Global Cancer Drugs Market by Region
8. Company Profiles and Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/research/n2qtrj/global_cancer?w=4